<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02920008</url>
  </required_header>
  <id_info>
    <org_study_id>SGI-110-06</org_study_id>
    <nct_id>NCT02920008</nct_id>
  </id_info>
  <brief_title>Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia</brief_title>
  <official_title>A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) Versus Treatment Choice in Adults With Previously Treated Acute Myeloid Leukemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Astex Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Astex Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicenter, randomized, open-label, parallel-group study of guadecitabine vs treatment
      choice (TC). Subjects will be randomly assigned in a 1:1 ratio to either guadecitabine or TC.
      TC options include the 8 high or low intensity, locally available regimens below; or Best
      supportive Care (BSC) alone:

        -  High intensity (intermediate or high dose cytarabine [HiDAC]; mitoxantrone, etoposide,
           and cytarabine [MEC]; or fludarabine, cytarabine, granulocyte colony stimulating factor
           [G-CSF], +/- idarubicin [FLAG/FLAG-Ida]).

        -  Low intensity (low dose cytarabine [LDAC], decitabine, or azacitidine).

        -  BSC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This Phase 3, randomized, open-label, parallel-group multicenter study of the efficacy and
      safety of guadecitabine in adults with previously treated AML will be conducted in
      approximately 20 countries. There will be a 14-day screening period, a treatment period, a
      safety follow-up visit, and a long-term follow-up period. The study is expected to last
      approximately 2 years. Duration of individual subject participation will vary, and subjects
      may continue to receive treatment for as long as they continue to benefit.

      Approximately 404 subjects from approximately 100 study centers will be randomly assigned to
      either guadecitabine or treatment choice (TC) in a 1:1 ratio (approximately 202 subjects per
      group). TC is as follows:

        -  High intensity: intermediate or high dose cytarabine (HiDAC); mitoxantrone, etoposide,
           and cytarabine (MEC); or fludarabine, cytarabine, G-CSF, +/- idarubicin (FLAG/FLAG-Ida).

        -  Low intensity: low dose cytarabine (LDAC), decitabine, or azacitidine.

        -  Best Supportive Care (BSC).

      Guadecitabine will be given SC at a dose of 60 mg/m2 in 28-day cycles. In Cycle 1,
      guadecitabine will be given for 10 days on Days 1-5 and Days 8-12. Cycle 2 will be either the
      5-day regimen (Days 1-5) or 10-day regimen (Days 1-5 and 8-12) based on assessment of disease
      response and hematologic recovery at the end of Cycle 1. In subsequent cycles, guadecitabine
      treatment will be for 5 days only (Days 1-5).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 16, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>24 months</time_frame>
    <description>Number of days from day subject was randomized to date of death, regardless of cause.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Event-free survival</measure>
    <time_frame>24 months</time_frame>
    <description>Number of days from randomization to earliest date of disease progression, treatment discontinuation, start of anti-leukemia therapy, or death.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long-term survival</measure>
    <time_frame>24 months</time_frame>
    <description>Survival at one year.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days alive and out of the hospital (NDAOH).</measure>
    <time_frame>24 months</time_frame>
    <description>Number of days subject alive and out of hospital during first 6 months of the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion independence rate</measure>
    <time_frame>24 months</time_frame>
    <description>Number of subjects without RBC or platelet transfusion for any 8-week period after treatment divided by total number of subjects in efficacy analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete response rate</measure>
    <time_frame>24 months</time_frame>
    <description>Number of subjects with best response of CR divided by total number of subjects in efficacy analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite complete response</measure>
    <time_frame>24 months</time_frame>
    <description>Number of subjects with best response of CR, CRp, or CRi divided by total number of subjects in efficacy analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematopoietic cell transplant (HCT) rate</measure>
    <time_frame>24 months</time_frame>
    <description>Number of subjects who received HCT after randomization divided by total number of subjects in efficacy analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of complete response (CR)</measure>
    <time_frame>24 months</time_frame>
    <description>Duration of CR (in number of days) will be calculated from the first time a CR is observed to time of relapse (defined as the earliest time point whereby BM assessment or PB assessment indicate relapse/disease progression due to confirmed reappearance of ≥5% leukemic blasts in PB or ≥5% leukemic blasts in BM.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>The calculation for EQ-5D-5L index value will be performed according to EuroQol group's EQ-5D-5L User Guide.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence and severity of adverse events</measure>
    <time_frame>24 months</time_frame>
    <description>Subject reported and investigator-observed AEs and 30- and 60-day all-cause mortality, along with clinical laboratory tests (hematology, chemistries), concomitant Medications, physical examination, vital signs, ECOG performance status and ECGs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30- and 60-day all-cause mortality</measure>
    <time_frame>24 months</time_frame>
    <description>Number of deaths, regardless of cause, within 30 or 60 days from the first study dose divided by the total number of subjects included in the safety analysis set.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">404</enrollment>
  <condition>Acute Myeloid Leukemia</condition>
  <arm_group>
    <arm_group_label>guadecitabine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Guadecitabine will be given SC at a dose of 60 mg/m2 in 28-day cycles (delayed as necessary to allow blood count recovery).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Choice (TC)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High intensity
Low intensity
Best supportive care (BSC).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>guadecitabine</intervention_name>
    <description>In Cycle 1, guadecitabine will be given for 10 days on Days 1-5 and Days 8-12. In Cycle 2, the guadecitabine dose will be 60 mg/m2 for either 10 days (Days 1-5 and 8-12) or 5 days (Days 1-5 only) based on assessment of disease response, and hematological recovery by Day ≥28.</description>
    <arm_group_label>guadecitabine</arm_group_label>
    <other_name>SGI-110</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Treatment Choice (TC)</intervention_name>
    <description>High intensity: Intermediate or high dose cytarabine (HiDAC).
Low intensity:
LDAC.
Decitabine.
Azacitidine.
Best supportive care only: given according to standard and institutional practice.</description>
    <arm_group_label>Treatment Choice (TC)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult subjects ≥18 years of age who are able to understand study procedures, comply
             with them, and provide written informed consent before any study-specific procedure.

          2. History of cytologically or histologically confirmed diagnosis of AML (except acute
             promyelocytic leukemia) according to the 2008 World Health Organization (WHO)
             classification (bone marrow [BM] or peripheral blood [PB] blast counts ≥20%).

          3. Performance status (Eastern Cooperative Oncology Group; ECOG) of 0-2.

          4. Subjects with AML previously treated with initial induction therapy using a standard
             intensive chemotherapy regimen, including cytarabine and an anthracycline, and who are
             refractory to initial induction (primary refractory) or in relapse after such initial
             induction with or without prior HCT.

          5. Subjects must have either PB or BM blasts ≥5% at time of randomization.

          6. Creatinine clearance or glomerular filtration rate ≥30 mL/min as estimated by the
             Cockroft-Gault (C-G) or other medically acceptable formulas, such as MDRD
             (Modification of Diet in Renal Disease) or CKD-EPI (the Chronic Kidney Disease
             Epidemiology Collaboration).

          7. Women of child-bearing potential must not be pregnant or breastfeeding and must have a
             negative pregnancy test at screening. Women of child-bearing potential and men with
             female partners of child-bearing potential must agree to practice 2 highly effective
             contraceptive measures of birth control and must agree not to become pregnant or
             father a child (a) while receiving treatment of guadecitabine, decitabine, or
             azacitidine and for at least 3 months after completing treatment and (b) while
             receiving treatment with high-intensity TC or LDAC and for at least 6 months after
             completing treatment.

        Exclusion Criteria:

          1. Known clinically active central nervous system (CNS) or extramedullary AML, except
             leukemia cutis.

          2. Subjects who are in first relapse after initial induction, if they had a response
             duration of &gt;12 months from date when first response first documented or if they are
             good candidates for HCT.

          3. BCR-ABL-positive leukemia (chronic myelogenous leukemia in blast crisis).

          4. Second malignancy currently requiring active therapy, except breast or prostate cancer
             stable on or responding to endocrine therapy.

          5. Grade 3 or higher Graft Versus Host Disease (GVHD), or GVHD on either a calcineurin
             inhibitor or prednisone more than 5 mg/day.

          6. Prior treatment with guadecitabine for any indication, or more than 2 cycles of prior
             decitabine or azacitidine.

          7. Hypersensitivity to decitabine, guadecitabine, or any of their excipients.

          8. Treated with any investigational therapy within 2 weeks of the first dose of study
             treatment.

          9. Total serum bilirubin &gt;2.5 × upper limit of normal (ULN; except for subjects with
             Gilbert's Syndrome for whom direct bilirubin is &lt;2.5 × ULN), or liver cirrhosis, or
             chronic liver disease Child-Pugh Class B or C.

         10. Known active human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis
             C virus (HCV) infection. Inactive hepatitis carrier status or low viral hepatitis
             titer on antivirals is allowed.

         11. Known significant mental illness or other condition such as active alcohol or other
             substance abuse or addiction that, in the opinion of the investigator, predisposes the
             subject to high risk of noncompliance with the protocol.

         12. Refractory congestive heart failure unresponsive to medical treatment; active
             infection resistant to all antibiotics; or non-AML-associated pulmonary disease
             requiring &gt;2 liters per minute (LPM) oxygen, or any other condition that puts the
             subject at an imminent risk of death.

         13. Subjects with high PB blasts &gt;50% AND poor ECOG PS of 2.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harold N Keer, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Astex Pharmaceuticals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laksmi Wilson</last_name>
    <phone>925-560-2914</phone>
    <email>laksmi.wilson@astx.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Harold N Keer, MD, PhD</last_name>
    <phone>925-560-2914</phone>
    <email>ASTRAL-2@astx.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Arizona Cancer Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724-0001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melaney Rayburn</last_name>
      <email>melaneyr@email.arizona.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Fernando</last_name>
      <phone>323-226-4182</phone>
      <email>donna.fernando@med.usc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Howard Weiner</last_name>
      <phone>773-702-2084</phone>
      <email>hweiner@medicine.bsd.uchicago.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Franciscan Research Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46237</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabella van der Merwe</last_name>
      <phone>317-528-7822</phone>
      <email>isabella.vandermerwe@franciscanalliance.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Theurer Cancer Center at Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601-1915</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gillian Velardi</last_name>
      <phone>551-996-5484</phone>
      <email>Gillian.Velardi@hackensackmeridian.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of New Mexico School of Medicine</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Weishampel</last_name>
      <phone>505-925-0027</phone>
      <email>dweishampel@salud.unm.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Roswell Park Cancer Institute</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Bashaw</last_name>
      <phone>716-845-4971</phone>
      <email>heather.bashaw@roswellpark.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Latia Skerving</last_name>
      <phone>212-746-5017</phone>
      <email>las2051@med.cornell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Hospital</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Munoz</last_name>
      <phone>631-638-0844</phone>
      <email>sebastian.munoz@stonybrookmedicine.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke Cancer Institute</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Stowe</last_name>
      <phone>919-681-4769</phone>
      <email>rachel.stowe@dm.duke.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104-5418</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Schuringa</last_name>
      <phone>405-271-8777</phone>
      <email>patricia-schuringa@ouhsc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tyler Sylk</last_name>
      <email>tyler.sylk@uphs.upenn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19111-2433</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lilanee Chanyothi</last_name>
      <phone>215-214-3035</phone>
      <email>lilanee.chanyothi@fccc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Channing Dudley</last_name>
      <phone>615-936-1936</phone>
      <email>channing.v.dudley@vanderbilt.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Research Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dolly Davis</last_name>
      <phone>214-820-6967</phone>
      <email>dolly.davis@bswhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ameena Manzoor</last_name>
      <phone>713-745-9941</phone>
      <email>amanzoor@mdanderson.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Swedish Cancer Institute</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neil Bailey</last_name>
      <phone>206-215-1471</phone>
      <email>neil.bailey@swedish.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Virginia University Hospitals, Inc.</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Beal</last_name>
      <phone>304-293-0609</phone>
      <email>pbeal@hsc.wvu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AZ Sint-Jan Brugge-Oostende AV</name>
      <address>
        <city>Brugge</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Salenbien</last_name>
      <phone>+32 50 45 30 62</phone>
      <email>laura.salenbien@azsintjan.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Celine Pedreira</last_name>
      <phone>+32 2 764 18 10</phone>
      <email>celine.pedreira@uclouvain.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Gent</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonas Segaert</last_name>
      <phone>+32 9 332 49 12</phone>
      <email>jonas.segaert@uzgent.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tom Baker Cancer Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeff Greenway</last_name>
      <phone>403-521-3452</phone>
      <email>jeff.greenway@ahs.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Alberta Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2V2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Lin</last_name>
      <phone>(780) 407-3805</phone>
      <email>jane.lin3@ahs.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Cancer Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Kim</last_name>
      <phone>(416) 946-4501</phone>
      <phone_ext>3592</phone_ext>
      <email>jennifer.kim@uhn.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>McGill University Health Centre</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Asmae Oulbacha</last_name>
      <phone>(514) 934-1934</phone>
      <phone_ext>34907</phone_ext>
      <email>asmae.oulbacha@muhc.mcgill.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Maisonneuve Rosemont</name>
      <address>
        <city>Montreal</city>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Trinh Lu</last_name>
      <phone>(514) 252-3400</phone>
      <phone_ext>3336</phone_ext>
      <email>jtlu.hmr@ssss.gouv.qc.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus C</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingrid Gejel</last_name>
      <phone>+45 7846 7917</phone>
      <email>ingrgeje@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de la Côte Basque</name>
      <address>
        <city>Bayonne</city>
        <zip>64100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edith Vincent</last_name>
      <phone>+33 5 59 44 39 39</phone>
      <email>evincent@ch-cotebasque.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Limoges</name>
      <address>
        <city>Limoges Cedex</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Céline Philippon</last_name>
      <phone>+33 5 55 05 88 62</phone>
      <email>celine.philippon@chu-limoges.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Conception</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maurine Duhayon</last_name>
      <phone>+33 4 91 38 29 71</phone>
      <email>maurine.duhayon@ap-hm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU Montpellier - Saint Eloi</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vera Sabadash</last_name>
      <phone>+33 4 67 33 24 12</phone>
      <email>v-sabadash@chu-montpellier.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier de la Région de Mulhouse et Sud Alsace</name>
      <address>
        <city>Mulhouse</city>
        <zip>68100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Céline Haby</last_name>
      <phone>+33 3 89 64 77 43</phone>
      <email>habyc@ghrmsa.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint-Louis</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Blandine Beve</last_name>
      <phone>+33 1 71 20 70 08</phone>
      <email>blandine.beve@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon-Sud</name>
      <address>
        <city>Pierre Bénite</city>
        <zip>69310</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed El Hamri</last_name>
      <phone>+33 4 78 86 22 20</phone>
      <email>mohamed.el-hamri@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Henri Becquerel</name>
      <address>
        <city>Rouen cedex 1</city>
        <zip>76038</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginie Bayon</last_name>
      <phone>+33 2 32 08 29 28</phone>
      <email>virginie.bayon@chb.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire du Cancer de Toulouse - Oncopole</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle De Ponnat</last_name>
      <phone>+33 5 31 15 63 59</phone>
      <email>deponnat.isabelle@iuct-oncopole.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>4103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Otto</last_name>
      <phone>(49) 341 97-13132</phone>
      <email>sandra.otto@medizin.uni-leipzig.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aline Schenk</last_name>
      <phone>+49 30 450 513 497</phone>
      <email>aline.schenk@charite.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Braunschweig gGmbH</name>
      <address>
        <city>Braunschweig</city>
        <zip>38114</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Streitbürger</last_name>
      <phone>+49 531 595 3700</phone>
      <email>o.streitbuerger@klinikum-braunschweig.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marien Hospital Düsseldorf GmbH</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40479</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vera Lohrbacher</last_name>
      <phone>+49 211 / 44 00 20 79</phone>
      <email>vera.lohrbacher@vkkd-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susanne Kappes</last_name>
      <phone>+49 761 270 35410</phone>
      <email>susanne.kappes@uniklinik-freiburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Halle (Saale)</name>
      <address>
        <city>Halle</city>
        <zip>6120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antje Kleinbauer</last_name>
      <phone>+49 345 557 2849</phone>
      <email>innere4.studienzentrale@uk-halle.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monika Fischer</last_name>
      <phone>+49 (0)6221 56- 5271</phone>
      <email>monika.fischer@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Trautmann-Harder</last_name>
      <phone>+49 431 500 22563</phone>
      <email>Silke.trautmann-harder@uksh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinischen Fakultät Mannheim der Universität Heidelberg</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michaela Hausmann</last_name>
      <phone>+49 621 383 6974</phone>
      <email>michaela.hausmann@umm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München</name>
      <address>
        <city>Muenchen</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Dörres</last_name>
      <phone>49-89- 4400-73152</phone>
      <email>daniela.doerres@med.uni-muenchen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olga Polack</last_name>
      <phone>+49381 494 7325</phone>
      <email>olga.polack@med.uni-rostock.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorothea Paul</last_name>
      <phone>+49731 500 45957</phone>
      <email>dorothea.paul@uniklinik-ulm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SE ÁOK I. sz. Belgyógyászati Klinika</name>
      <address>
        <city>Budapest</city>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gyorgy Nagy</last_name>
      <phone>+36 20 943 6465</phone>
      <email>gyorgypalnagy@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Debreceni Egyetem Klinikai Központ</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriella Mezei</last_name>
      <phone>36306575238</phone>
      <email>gmezei@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Somogy Megyei Kaposi Mór Oktató Kórház</name>
      <address>
        <city>Kaposvar</city>
        <zip>7400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Éva Meskuláné Szilágyi</last_name>
      <phone>(368) 250-1341</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pecsi Tudomanyegyetem Klinikai Központ</name>
      <address>
        <city>Pécs</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gábor Kollár</last_name>
      <phone>+36 30 5424314</phone>
      <email>gkollar32@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Szegedi Tudományegyetem</name>
      <address>
        <city>Szeged</city>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agnes Nagyne</last_name>
      <phone>+36 70 439 11 36</phone>
      <email>nagyne.agi.szte@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS AOU San Martino - IST</name>
      <address>
        <city>Genova</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianna Fava</last_name>
      <phone>39-10-555-4337</phone>
      <email>marianna.fava.hsm@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppina Biscardi</last_name>
      <phone>+39 02 55033050</phone>
      <email>giuseppina.biscardi@policlinico.mi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele - Milano</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefania Trinca</last_name>
      <phone>+39 2264342890</phone>
      <email>trinca.stefania@hsr.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O.R.N. &quot;A. Cardarelli&quot;</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luisa Copia</last_name>
      <phone>+39 081 7472 401</phone>
      <email>luisacopia@libero.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Presidio San Salvatore Muraglia</name>
      <address>
        <city>Pesaro</city>
        <zip>61122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Federica Loscocco</last_name>
      <phone>+390721360422</phone>
      <email>federica.loscocco@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Eugenio</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giulia Ceccarelli</last_name>
      <phone>+39 339 1675305</phone>
      <email>g.ceccarellidm@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.S.U Integrata di Udine - Presidio Ospedaliero Santa Maria della Misericordia</name>
      <address>
        <city>Udine</city>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Dodorico</last_name>
      <phone>+39-432-559701</phone>
      <email>cristina.dodorico@asuiud.sanita.fvg.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Akita University Hospital</name>
      <address>
        <city>Akita-shi</city>
        <zip>010-8543</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manami Kudo</last_name>
      <phone>+81-18-884-6216</phone>
      <email>m.kudo-357@hos.akita-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nippon Medical School Hospital</name>
      <address>
        <city>Bunkyō-Ku</city>
        <zip>113-8603</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Asuka Sekiguchi</last_name>
      <phone>+81-3-3822-2131</phone>
      <email>sekiguchi@nms.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chugoku Central Hospital</name>
      <address>
        <city>Fukuyama-Shi</city>
        <zip>720-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miho Matsumoto</last_name>
      <phone>81-84-970-2121</phone>
      <email>matumoto-miho@kouritu-cch.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tokai University Hospital</name>
      <address>
        <city>Isehara-shi</city>
        <zip>259-1193</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akiko Yamamoto</last_name>
      <phone>81-463-93-1121</phone>
      <email>aki-y@tokai-u.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saitama Medical Center</name>
      <address>
        <city>Kawagoe-Shi</city>
        <zip>350-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoshiko Murakami</last_name>
      <phone>81-49-228-3902</phone>
      <email>y-murakami@epsogo.co.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kobe City Medical Center General Hospital</name>
      <address>
        <city>Kobe-shi</city>
        <zip>650-0047</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miyuki Okitsu</last_name>
      <phone>+81-78-302-4321</phone>
      <email>miyuki_okitsu@kcho.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Cancer Institute Hospital of Japanese Foundation for Cancer Research (JFCR)</name>
      <address>
        <city>Koto-Ku</city>
        <zip>135-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuta Toyosawa</last_name>
      <phone>+81-3-3520-111</phone>
      <email>y-toyosawa@epsogo.co.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Japanese Red Cross Kyoto Daini Hospital</name>
      <address>
        <city>Kyoto-shi</city>
        <zip>602-8026</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miki Tsuruno</last_name>
      <phone>81-75-212-9645</phone>
      <email>miki-tsuruno@jp-smo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital, Kyoto Prefectural University of Medicine</name>
      <address>
        <city>Kyoto-shi</city>
        <zip>602-8566</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miki Miyamoto</last_name>
      <phone>81-75-251-5111</phone>
      <email>m-miyamoto@epsogo.co.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gunmaken Saiseikai Maebashi Hospital</name>
      <address>
        <city>Maebashi-shi</city>
        <zip>371-0821</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noriko Seki</last_name>
      <phone>+81-27-252-6011</phone>
      <email>no-seki@maebashi.saiseikai.or.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nagasaki University Hospital</name>
      <address>
        <city>Nagasaki-shi</city>
        <zip>852-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mineko Okuzono</last_name>
      <phone>092-437-3303</phone>
      <email>m-okuzono@epsogo.co.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Japanese Red Cross Nagasaki Genbaku Hospital</name>
      <address>
        <city>Nagasaki-Shi</city>
        <zip>852-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keiko Kamichika</last_name>
      <phone>81-95-847-1511</phone>
      <email>keiko-kamichika@j-smo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Japanese Red Cross Narita Hospital</name>
      <address>
        <city>Narita-shi</city>
        <zip>286-8523</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yukiko Takada</last_name>
      <phone>+81-80-6550-9863</phone>
      <email>takada.yukiko@e-smo.co.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kindai University Hospital</name>
      <address>
        <city>Osakasayama-Shi</city>
        <zip>589-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoko Maeda</last_name>
      <phone>072-366-0221</phone>
      <email>yoko-maeda@med.kindai.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saga University Hospital</name>
      <address>
        <city>Saga-shi</city>
        <zip>849-8501</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akemi Sato</last_name>
      <phone>81-952-34-3400</phone>
      <email>satoha@cc.saga-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NTT Medical Center Tokyo</name>
      <address>
        <city>Shinagawa-Ku</city>
        <zip>141-8625</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Masako Suzuki</last_name>
      <phone>03-5475-6112</phone>
      <email>suzukimasako@csnt.co.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shizuoka Cancer Center</name>
      <address>
        <city>Shizuoka</city>
        <zip>411-8777</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Takuya Nakashima</last_name>
      <phone>+81-55-989-5222</phone>
      <email>t.nakashima@scchr.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Disaster Medical Center</name>
      <address>
        <city>Tachikawa-Shi</city>
        <zip>190-0014</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Syoko Fujita</last_name>
      <phone>81-42-526-5511</phone>
      <email>syokofujita@tdmc.hosp.go.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yamagata University Hospital</name>
      <address>
        <city>Yamagata-Shi</city>
        <zip>990-9585</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sachiko Osawa</last_name>
      <phone>81-23-628-5840</phone>
      <email>sosat@med.id.yamagata-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Fukui Hospital</name>
      <address>
        <city>Yoshida-Gun</city>
        <zip>910-1193</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuka Matsuo</last_name>
      <phone>+81-776-61-8529</phone>
      <email>yuka927@u-fukui.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>5505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eun Jin Kim</last_name>
      <phone>+82 31 787 8319</phone>
      <email>r1598@snubh.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pusan National University Hospital</name>
      <address>
        <city>Busan</city>
        <zip>49241</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jinyi Baek</last_name>
      <phone>82-51-240-7078</phone>
      <email>forawayz@naver.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>3080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ju-Hyun Lee</last_name>
      <phone>+82 2 2072 7617</phone>
      <email>lee-jh8368@daum.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>3722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>So-Young Choi</last_name>
      <phone>(822) 222-8424</phone>
      <phone_ext>6</phone_ext>
      <email>so-youngchoi@yuhs.ac</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>5505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyangki Lee</last_name>
      <phone>+82 2 3010 7277</phone>
      <email>hklee122@amc.seoul.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>6351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jayeon Kim</last_name>
      <phone>+82 2 2148 7390</phone>
      <email>jy0760.kim@samsung.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea, Seoul St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>6591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eunha Kim</last_name>
      <phone>+82 2 2258 7588</phone>
      <email>eun3457@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ulsan University Hospital (UUH)</name>
      <address>
        <city>Ulsan</city>
        <zip>44033</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hae Jin Kang</last_name>
      <phone>+82 52 230 1421</phone>
      <email>uuhimpjina@naver.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny Nr. 1</name>
      <address>
        <city>Lublin</city>
        <zip>20-081</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olga Jankowska-Lecka</last_name>
      <phone>48691722991</phone>
      <email>olga.jank@wp.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instytut Hematologii i Transfuzjologi</name>
      <address>
        <city>Warszawa</city>
        <zip>02-776</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malgorzata Makowska</last_name>
      <phone>48223496454</phone>
      <email>mmakowska@ihit.waw.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Łodzi</name>
      <address>
        <city>Łódź</city>
        <zip>93-513</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucyna Rolczak</last_name>
      <phone>+48426895191</phone>
      <email>lucyna.rolczak@wp.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>8036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toni de la Riva</last_name>
      <phone>+34 93 227 54 28</phone>
      <email>delariva@clinic.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>8041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pepa Rosal Muntadas-Prim</last_name>
      <phone>+34 93.553.71.21</phone>
      <email>rmuntadas@santpau.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesc Garcia Pallarols</last_name>
      <phone>+34 93 248 33 43</phone>
      <email>fgarcia1@imim.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vall d'Hebron Institut d'Oncologia</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Verónica Motino Godoy</last_name>
      <phone>+34 932746100</phone>
      <phone_ext>4976</phone_ext>
      <email>vmotino@vhio.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital San Pedro de Alcántara</name>
      <address>
        <city>Cáceres</city>
        <zip>10003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmen Alcaine</last_name>
      <phone>+34 927 256 200</phone>
      <email>mamenalca@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofía</name>
      <address>
        <city>Córdoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inmaculada Ruíz Cáceres</last_name>
      <phone>+34 697 95 93 54</phone>
      <email>datamanager1hurs@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Hernández Martín</last_name>
      <phone>+34 915868394</phone>
      <email>martama.hernandez@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paloma Ramos</last_name>
      <phone>34913368967</phone>
      <email>pramos_3@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <zip>33011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Estefania Vargas</last_name>
      <phone>34676865405</phone>
      <email>fannypardavila@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Celia Cifuentes</last_name>
      <phone>+34955013277</phone>
      <email>celiacifuentes.ensayos@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Dr. Peset</name>
      <address>
        <city>Valencia</city>
        <zip>46017</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Ivars</last_name>
      <phone>+34 961622798</phone>
      <email>david.ivars@uv.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari i Politècnic La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Pellicer</last_name>
      <phone>+34 961 244 864</phone>
      <email>pellicer_dav@gva.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Khmelnytskyi Regional Hospital</name>
      <address>
        <city>Khmelnytskyi</city>
        <zip>29000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oleksandr Hordiienko</last_name>
      <phone>380504072150</phone>
      <email>studycoordin@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Heart of England NHS Foundation Trust - Heartlands Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B9 5SS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sundip Sohanpal</last_name>
      <phone>+44-121-4241075</phone>
      <email>sundip.sohanpal@heartofengland.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospitals Bristol NHS Foundation Trust - Bristol Haematology and Oncology Centre</name>
      <address>
        <city>Bristol</city>
        <zip>BS2 8ED</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helen Saldanha</last_name>
      <phone>+44 (0) 117 3426740</phone>
      <email>helen.saldanha@uhbristol.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>East Kent Hospitals University NHS Foundation Trust - Kent and Canterbury Hospital</name>
      <address>
        <city>Canterbury</city>
        <zip>CT1 3NG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lavina Davey</last_name>
      <phone>+44 1227863161</phone>
      <email>laviniadavey@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. James's University Hospital</name>
      <address>
        <city>Leeds</city>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zoe Kenworthy</last_name>
      <phone>+44 113 206 8577</phone>
      <email>zoe.kenworthy@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Imperial College Healthcare NHS Trust - Hammersmith Hospital</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christos Paliompeis</last_name>
      <phone>+44 2083834715</phone>
      <email>christos.paliompeis@nhs.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2016</study_first_submitted>
  <study_first_submitted_qc>September 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2016</study_first_posted>
  <last_update_submitted>May 18, 2018</last_update_submitted>
  <last_update_submitted_qc>May 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>AML, acute myeloid leukemia, guadecitabine, SGI-110, Phase 3</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Leukemia, Myeloid</mesh_term>
    <mesh_term>Leukemia, Myeloid, Acute</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Azacitidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

